The Role of HDAC3 in Inflammation: Mechanisms and Therapeutic Implications

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Jul 25

PMID 39050859

Authors

Noah Watson

Sivaraman Kuppuswamy

William Luke Ledford

Sangeetha Sukumari-Ramesh

Affiliations

Soon will be listed here.

Abstract

Histone deacetylases (HDACs) are critical regulators of inflammatory gene expression, and the efficacy of pan-HDAC inhibitors has been implicated in various disease conditions. However, it remains largely unclear how HDACs precisely regulate inflammation. To this end, evaluating the isoform-specific function of HDACs is critical, and the isoform-specific targeting could also circumvent the off-target effects of pan-HDAC inhibitors. This review provides an overview of the roles of HDAC3, a class I HDAC isoform, in modulating inflammatory responses and discusses the molecular mechanisms by which HDAC3 regulates inflammation associated with brain pathology, arthritis, cardiovascular diseases, lung pathology, allergic conditions, and kidney disorders. The articles also identify knowledge gaps in the field for future studies. Despite some conflicting reports, the selective inhibition of HDAC3 has been demonstrated to play a beneficial role in various inflammatory pathologies. Exploring the potential of HDAC3 inhibition to improve disease prognosis is a promising avenue requiring further investigation.

Citing Articles

An 8-Week Very Low-Calorie Ketogenic Diet (VLCKD) Alters the Landscape of Obese-Derived Small Extracellular Vesicles (sEVs), Redefining Hepatic Cell Phenotypes.

Balestra F, De Luca M, Panzetta G, Depalo N, Rizzi F, Mastrogiacomo R Nutrients. 2024; 16(23).

PMID: 39683581 PMC: 11643994. DOI: 10.3390/nu16234189.

Mapping the evolution and impact of ketogenic diet research on diabetes management: a comprehensive bibliometric analysis from 2005 to 2024.

Li Z, Li A, Liu P, Zhang B, Yan Y Front Nutr. 2024; 11:1485642.

PMID: 39483785 PMC: 11527367. DOI: 10.3389/fnut.2024.1485642.

Histone Deacetylases (HDACs) Roles in Inflammation-mediated Diseases; Current Knowledge.

Jasim S, Altalbawy F, Abohassan M, Oghenemaro E, Kumar Bishoyi A, Singh R Cell Biochem Biophys. 2024; .

PMID: 39419931 DOI: 10.1007/s12013-024-01587-0.

References

Lahm A, Paolini C, Pallaoro M, Nardi M, Jones P, Neddermann P . Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A. 2007; 104(44):17335-40. PMC: 2077257. DOI: 10.1073/pnas.0706487104. View

Wang Y, Xie X, Zhang C, Su M, Gao S, Wang J . Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood. Ann Rheum Dis. 2021; 81(3):379-385. PMC: 8862024. DOI: 10.1136/annrheumdis-2021-220066. View

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

Li Y, Liu C, Wang G, Wang H, Liu X, Huang C . HDAC3 inhibitor (BRD3308) modulates microglial pyroptosis and neuroinflammation through PPARγ/NLRP3/GSDMD to improve neurological function after intraventricular hemorrhage in mice. Neuropharmacology. 2023; 237:109633. DOI: 10.1016/j.neuropharm.2023.109633. View

Mullican S, Gaddis C, Alenghat T, Nair M, Giacomin P, Everett L . Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 2011; 25(23):2480-8. PMC: 3243058. DOI: 10.1101/gad.175950.111. View

Li Y, Lui K, Zhou B . Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases. Nat Rev Cardiol. 2018; 15(8):445-456. DOI: 10.1038/s41569-018-0023-y. View

Adcock I . HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol. 2007; 150(7):829-31. PMC: 2013887. DOI: 10.1038/sj.bjp.0707166. View

Leus N, van der Wouden P, van den Bosch T, Hooghiemstra W, Ourailidou M, Kistemaker L . HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Biochem Pharmacol. 2016; 108:58-74. PMC: 4844503. DOI: 10.1016/j.bcp.2016.03.010. View

Yaturu S, Humphrey S, Landry C, Jain S . Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit. 2008; 15(1):CR5-9. View

10.

Sun X, Liu Y, Feng X, Li C, Li S, Zhao Z . The key role of macrophage depolarization in the treatment of COPD with ergosterol both in vitro and in vivo. Int Immunopharmacol. 2019; 79:106086. DOI: 10.1016/j.intimp.2019.106086. View

11.

Lee D, HAYES J, Pruss D, Wolffe A . A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 1993; 72(1):73-84. DOI: 10.1016/0092-8674(93)90051-q. View

12.

Chen L, Shang C, Wang B, Wang G, Jin Z, Yao F . HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis. Biochem Pharmacol. 2021; 192:114716. DOI: 10.1016/j.bcp.2021.114716. View

13.

Ritchlin C, Dwyer E, Bucala R, Winchester R . Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand J Immunol. 1994; 40(3):292-8. DOI: 10.1111/j.1365-3083.1994.tb03465.x. View

14.

Guo F, Li X, Chen L, Yang H, Dai H, Wei Y . [Study of relationship between inflammatory response and apoptosis in perihematoma region in patients with intracerebral hemorrhage]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006; 18(5):290-3. View

15.

Angiolilli C, Kabala P, Grabiec A, Van Baarsen I, Ferguson B, Garcia S . Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis. 2016; 76(1):277-285. PMC: 5264225. DOI: 10.1136/annrheumdis-2015-209064. View

16.

Ziesche E, Kettner-Buhrow D, Weber A, Wittwer T, Jurida L, Soelch J . The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. Nucleic Acids Res. 2012; 41(1):90-109. PMC: 3592411. DOI: 10.1093/nar/gks916. View

17.

Gunawardhana L, Gibson P, Simpson J, Powell H, Baines K . Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma. Clin Exp Allergy. 2013; 44(1):47-57. DOI: 10.1111/cea.12168. View

18.

Marks P, Richon V, Rifkind R . Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst. 2000; 92(15):1210-6. DOI: 10.1093/jnci/92.15.1210. View

19.

Choo Q, Ho P, Tanaka Y, Lin H . Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. Rheumatology (Oxford). 2010; 49(8):1447-60. DOI: 10.1093/rheumatology/keq108. View

20.

Shakespear M, Halili M, Irvine K, Fairlie D, Sweet M . Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011; 32(7):335-43. DOI: 10.1016/j.it.2011.04.001. View